BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1988724)

  • 1. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
    Koenig K; Padalino P; Alexandrides G; Pak CY
    J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
    Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
    Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Wuermser LA; Poindexter J; Pak CY
    J Clin Pharmacol; 1998 Nov; 38(11):1035-41. PubMed ID: 9824785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of citrate from two different preparations of potassium citrate.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Pharmacol; 1989 Apr; 29(4):338-41. PubMed ID: 2723122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of various potassium salts on renal citrate excretion.
    Sakhaee K; Alpern R; Jacobson HR; Pak CY
    J Clin Endocrinol Metab; 1991 Feb; 72(2):396-400. PubMed ID: 1899422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Pak CY
    Am J Kidney Dis; 1999 Jul; 34(1):107-13. PubMed ID: 10401023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
    Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
    J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate and renal calculi: new insights and future directions.
    Pak CY
    Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citraturic response to oral citric acid load.
    Sakhaee K; Alpern R; Poindexter J; Pak CY
    J Urol; 1992 Apr; 147(4):975-6. PubMed ID: 1552616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
    Pak CY; Koenig K; Khan R; Haynes S; Padalino P
    J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium bioavailability from magnesium citrate and magnesium oxide.
    Lindberg JS; Zobitz MM; Poindexter JR; Pak CY
    J Am Coll Nutr; 1990 Feb; 9(1):48-55. PubMed ID: 2407766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
    Odvina CV; Mason RP; Pak CY
    Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
    Lindberg J; Harvey J; Pak CY
    J Urol; 1990 Feb; 143(2):248-51. PubMed ID: 2299712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkali Citrate Content of Common Over-the-Counter and Medical Food Supplements.
    Dai JC; Maalouf NM; Hill K; Antonelli JA; Pearle MS; Johnson BA
    J Endourol; 2023 Jan; 37(1):112-118. PubMed ID: 35972746
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism.
    Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P
    Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of renal citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship.
    Pak CY; Skurla C; Brinkley L; Sakhaee K
    J Clin Pharmacol; 1984 Jan; 24(1):19-26. PubMed ID: 6707230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.